Implementation of a Social and Mental Health Support to Promote Recovery in Five Mental Health Facilities in Paris Area

Launched by VERSAILLES HOSPITAL · Mar 1, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on improving recovery for individuals with severe mental disorders by implementing social and mental health support in five facilities around Paris. The study aims to understand how patients, their families, and healthcare professionals can benefit from this supportive approach as they work towards recovery. It will follow participants over time to see how their experiences change with the intervention.

To be eligible for the trial, participants need to have a severe mental disorder such as schizophrenia, recurrent mood disorders, or certain developmental disorders like autism. They must also receive approval from their psychiatrist to join the study and provide written consent. Participants can expect to engage with a team that will support their recovery, but it's important to note that individuals with unstable neurological conditions, severe personality disorders, or those currently in crisis may not be included in the study. Overall, this trial hopes to create a positive impact on mental health recovery through collaborative support.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Presence of a severe and persistent mental disorder among the following ICD10 compliant diagnostic categories:
• • Schizophrenia spectrum disorder (F2x)
• • Recurrent or persistent mood disorders (F30.x, F31.x, F33.x, F34.x, F38.x)
• • Psychological developmental disorders including autism spectrum disorders (F8x) and childhood and adolescent onset disorders (F9x)
• • Presence of an indication for inclusion in the rehabilitation project identified by the treating psychiatrist and endorsed in the inclusion session by the PASSVers staff.
• • Written consent from the patient or his/her legal representative to participate in the study.
• Exclusion Criteria:
• • Presence of an not stabilized or progressive organic neurological pathology, neurodegenerative disease
• • Psychological or behavioral disorders mainly related to addictions with substances
• • Psychiatric disorders secondary to an organic pathology that is not stabilized or that is evolving
• * The following psychiatric situations are reasons for non-inclusion in the absence of an argued and collegial reassessment (the reason being that, although PASSVers2 must be considered as a first intention proposal in many situations meeting the inclusion criteria, it cannot intervene or be thought of as a "solution" to certain complex situations):
• • Psychiatric disorders caused by pregnancy or immediate postpartum
• • Severe borderline personality disorder
• • Current suicidal crisis
• • Extreme fragility of the patient with respect to changes that may be induced by the project, associated with a high risk of self or hetero-aggression.
• • Patient under justice constraint
• • Foreseeable departure from the geographic area, not allowing for certainty of further evaluation
• • Refusal of the patient to be followed by a social-health team (i.e. refusal of care or refusal of a dialogue on social aspects and projects).